9567611000001102: Erlotinib hydrochloride (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

31119101000001117 Erlotinib hydrochloride (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

31119201000001112 Erlotinib hydrochloride en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erlotinib hydrochloride	Is a	Erlotinib	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely erlotinib (as erlotinib hydrochloride) 100 milligram/1 each conventional release oral tablet	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Product containing precisely erlotinib (as erlotinib hydrochloride) 150 milligram/1 each conventional release oral tablet	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Tarceva 100mg tablets (Roche Products Ltd)	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Tarceva 150mg tablets (Roche Products Ltd)	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Erlotinib 100mg tablets 30 tablet	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Erlotinib 150mg tablets 30 tablet	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Tarceva 100mg tablets (Roche Products Ltd) 30 tablet	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier
Tarceva 150mg tablets (Roche Products Ltd) 30 tablet	Has active ingredient	False	Erlotinib hydrochloride	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets